Thus, some studies revealed that suppression of HO-1 activity or HO-1 knockdown by siRNA increased the chemosensitivity of AML cells, pancreatic and lung cancer cells [9], [14], [16], but was not effective in other cancer cells [17]. This evidence concerns the gene HMOX1 and lung cancer.